Skip to content

Biomarkers in synovial fluid and serum as an indicator for the health status of the knee joint.

Biomarkers in synovial fluid and serum as an indicator for the health status of the knee joint. - JointScan

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON51053
Enrollment
48
Registered
2021-09-14
Start date
2022-07-12
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cartilage degeneration Osteoarthritis

Interventions

None listed

Sponsors

Deventer Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patient will undergo knee arthroscopy, intra-articular injection in the knee, or partial or total knee replacement surgery; - Patient is willing and able to provide informed consent for the study.

Exclusion criteria

Exclusion criteria: - Contra-indications to undergo knee arthroscopy, intra-articular injection in the knee, or partial or total knee replacement.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study is the relationship between biomarker levels and joint health status.

Secondary

MeasureTime frame
The secondary outcome of the study is the correlation between biomarker levels in serum and synovial fluid.

Countries

Netherlands

Contacts

Public ContactE.B.M. Landman

Deventer Ziekenhuis

wetenschapsbureau@dz.nl0570 535353

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)